Reduced- versus full-dose anticoagulants for the extended treatment of cancer-associated venous thromboembolism in Thai patients
Older age and a history of previous bleeding were associated with the use of reduced-dose anticoagulants. Patients with cancer-associated VTE receiving reduced-dose anticoagulants had a numerically higher risk of recurrent VTE and lower bleeding outcomes compared with those receiving full-dose anticoagulants.
Authors
- Pichika Chantrathammachart (ORCID: https://orcid.org/0000-0003-2267-6282)
- Kochawan Boonyawat (ORCID: https://orcid.org/0000-0003-3475-9173)
- Pantep Angchaisuksiri (ORCID: https://orcid.org/0000-0001-5607-3485)
- Pimjai Niparuck (ORCID: https://orcid.org/0000-0002-9422-9353)
- Kawin Vichaidit
- Teeraya Puawilai
Institutions
- Ramathibodi Hospital (TH)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1016/j.rpth.2024.102643
- Citations
- 4
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.20
Funders
- University of North Carolina Wilmington